drugset / Trial / NCT01145612
Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the efficacy of Losartan versus Atenolol in the progression of aortic dilatation in patients with Marfan syndrome.
Timeline
- Start
- 2008-10
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atenolol | Other / unclassified | 25 mg | — |
| Subject | Atenolol | Other / unclassified | 50 mg | — |
| Subject | Losartan | Other / unclassified | 25 mg | — |
| Subject | Losartan | Other / unclassified | 50 mg | — |